Recursion Pharmaceuticals (RXRX) concluded the recent trading session at $4.77, signifying a -1.24% move from its prior day's close.

Self-Referential Large Models: Recursive Self-Enhancement in Code Generation ...

Today we have two segments on cancer care. Later we will be joined by Ron Alfa, co-founder and CEO of Noetik. But first, I'm pleased to be joined by Colin Murdoch, president of Isomorphic Labs.

We recently published 10 Best Biotech Stocks to Buy Under $10. Recursion Pharmaceuticals, Inc. is placed eighth among them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage ...

Autonomous AI agents are more than just extensions of vendor tools. They’re credentialed actors who connect and execute, and ...

Recently, Hangzhou Xiaodao Technology Co., Ltd. announced that its applied patent titled "A Method and System for Generating Automated Repair Suggestions for AI Security Vulnerabilities" (Publication ...

If models don’t matter, what does? More specifically, how can you get AI to behave in a manner that's relevant and ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Running the AIO citations through its AI Detection Lite 1.0.1 model, the company found that 10.4 percent of them were likely ...

Code intelligence platform startup CoreStory launched today with an artificial intelligence-powered platform that turns ...

Perhaps such a transition will be increasingly adaptive. Faced with growing ecological and social crises, the current ...

Eliezer Yudkowsky and Nate Soares argue AI could legitimately take over the world in their new book, If Anyone Builds it, ...